Rash News and Research

RSS

Nigeria and DRC take action with new mpox vaccine rollouts

Nigeria is to begin the immediate rollout of 5,000 doses of mpox vaccines while the Democratic Republic of Congo (DRC) eyes its first shipment of 65,000 doses, as Africa steps up measures to control the multi-country outbreak.

30 Aug 2024

CDC identifies new Oropouche virus cases in U.S. travelers, raising public health concerns

The CDC reports 21 new cases of Oropouche virus among U.S. travelers from Brazil and Cuba, highlighting potential health risks and the need for vigilant monitoring and preventive measures.

29 Aug 2024

Healthcare workers unprepared for mpox outbreak due to knowledge gaps and vaccine inequity

Research highlights significant gaps in healthcare workers' knowledge of mpox during the 2022-2023 outbreaks, emphasizing the need for better global preparedness and equitable vaccine access.

27 Aug 2024

Study reveals long COVID's wide impact on children's health

The kids were correct all along. In the most comprehensive national study since the onset of the COVID-19 pandemic, a team of researchers that includes a Rutgers-organized consortium of pediatric sites has concluded that long COVID symptoms in children are tangible, pervasive, wide ranging and clinically distinct within specific age groups.

22 Aug 2024

New index identifies school-age children likely to have long COVID

A research team led by the National Institutes of Health's RECOVER Initiative and supported by its Clinical Science Core (CSC) at NYU Langone Health, has designed a new way to identify which school-age children and adolescents most likely have Long COVID.

21 Aug 2024

Scientists produce a genetic analysis of Lyme disease bacteria

A team led by CUNY Graduate Center biologists has produced a genetic analysis of Lyme disease bacteria that may pave the way for improved diagnosis, treatment, and prevention of the tick-borne ailment.

16 Aug 2024

Mapping Lyme bacteria for better patient care

A genetic analysis of Lyme disease bacteria may pave the way for improved diagnosis, treatment and prevention of the tick-borne ailment.

16 Aug 2024

CDC study reveals significantly higher Lyme disease rates among older adults than previously reported

The CDC and University of Iowa conducted an epidemiological study using Medicare data, revealing a seven-fold higher incidence of Lyme disease diagnoses among U.S. adults aged 65+ compared to public health surveillance data, particularly in high-incidence states.

15 Aug 2024

Common oral antibiotics tied to increased risk of severe drug-induced rashes

Two classes of commonly prescribed oral antibiotics are associated with the greatest risk for severe drug rashes that can lead to emergency department visits, hospitalizations and even death, according to a new study.

8 Aug 2024

Study reveals impact of climate change on enterovirus outbreaks

Outbreaks of hand, foot and mouth disease (HFMD), which causes fever and rash in young children, typically occur in the summer months.

6 Aug 2024

World-famous wall drug isn’t immune from challenges facing rural pharmacies

Stacey Schulz parks in a rear lot to avoid the crowded Main Street entrances to her local pharmacy.

24 Jul 2024

Evaluation and treatment of early Lyme disease

Every year in the United States, an estimated 476,000 people are diagnosed and treated for Lyme disease. The estimate comes from the U.S. Centers for Disease Control and Prevention (CDC).

23 Jul 2024

New deadly strain of mpox found in DRC could spread exponentially among humans

Concerns are growing about an outbreak of deadly mpox caused by a novel, sexually transmitted strain of the virus in the southeast of the Democratic Republic of Congo (DRC).

5 Jul 2024

Researchers discover role of particular protein in the development of lupus

A research team of Professor Yoontae Lee and Jiho Park, a PhD candidate, from the Department of Life Sciences at Pohang University of Science and Technology (POSTECH) recently discovered that a particular protein promotes the development of systemic lupus erythematosus (SLE).

1 Jul 2024

Clinical trial seeks to evaluate safety of new EV-D68 treatment

The National Institutes of Health (NIH) is sponsoring a clinical trial to evaluate the safety of an investigational monoclonal antibody to treat enterovirus D68 (EV-D68), which can cause severe respiratory and neurological diseases such as acute flaccid myelitis (AFM) – similar to polio. Scientists are striving to better understand AFM, which has emerged in the United States with spikes in cases every other year, primarily in the late-summer months over the last decade.

28 Jun 2024

Intermittent fasting outperforms traditional drugs in managing early type 2 diabetes

Study shows that a 5:2 intermittent fasting meal replacement diet effectively controls blood glucose levels and reduces body weight in Chinese adults with early type 2 diabetes. This dietary intervention outperforms metformin and empagliflozin in managing diabetes and obesity.

24 Jun 2024

Tips to help keep feet healthy during summer and prevent athlete’s foot

As the days heat up and we head into the Summer, many of us suddenly seem to remember that the appendages at the end of our legs need some love and care too.

22 Jun 2024

Multi-center study validates systemic score in identifying high-risk patients with Still's disease

A multi-centre, observational, prospective study was designed to evaluate the clinical usefulness of the systemic score in predicting life-threatening evolution – defined as the development of macrophage activation syndrome (MAS) and/or mortality.

12 Jun 2024

New study highlights ongoing mpox cases among gay and bisexual men in the U.S.

While mpox cases have sharply declined since the 2022 global outbreak, they continue to occur in the U.S. among gay and bisexual men who have sex with men (GBMSM), according to a UCLA-led study from EMERGEncy ID NET, a multisite surveillance network funded by the Centers for Disease Control and Prevention (CDC).

6 Jun 2024

New treatment approach could offer longer lasting protection to people with breast cancer

Killing breast cancer cells in a way that trains the immune system to recognize and destroy residual cancer cells could offer longer lasting protection to people with the disease, according to new research funded by Breast Cancer Now.

3 Jun 2024